149 related articles for article (PubMed ID: 16246947)
21. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S
Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981
[TBL] [Abstract][Full Text] [Related]
22. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.
Chen KJ; Shi DZ; Xu H; Lü SZ; Li TC; Ke YN; Zhang MZ; Lu XY; Sun RY; You SJ
Chin Med J (Engl); 2006 Jan; 119(1):6-13. PubMed ID: 16454975
[TBL] [Abstract][Full Text] [Related]
23. High-dose intracoronary irradiation after de novo stent implantation results of the EVEREST (Evaluation of Endoluminal Radiation in Elective Stenting) trial.
Geiger MH; Ludwig J; Burckhard R; Scheinert D; Müller RG; Daniel WG; Sauer R; Strnad V
Strahlenther Onkol; 2006 Jan; 182(1):9-15. PubMed ID: 16404515
[TBL] [Abstract][Full Text] [Related]
24. Influence of a pressure gradient distal to implanted bare-metal stent on in-stent restenosis after percutaneous coronary intervention.
Jensen LO; Thayssen P; Thuesen L; Hansen HS; Lassen JF; Kelbaek H; Junker A; Hansen KN; Boetker HE; Krusell LR; Pedersen KE
Circulation; 2007 Dec; 116(24):2802-8. PubMed ID: 18025527
[TBL] [Abstract][Full Text] [Related]
25. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
[TBL] [Abstract][Full Text] [Related]
26. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.
Kelbaek H; Thuesen L; Helqvist S; Kløvgaard L; Jørgensen E; Aljabbari S; Saunamäki K; Krusell LR; Jensen GV; Bøtker HE; Lassen JF; Andersen HR; Thayssen P; Galløe A; van Weert A;
J Am Coll Cardiol; 2006 Jan; 47(2):449-55. PubMed ID: 16412876
[TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
28. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty.
Wang G; Wei J; Guan Y; Jin N; Mao J; Wang X
Metabolism; 2005 May; 54(5):590-7. PubMed ID: 15877288
[TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular changes associated with inhibitory effect of pioglitazone on neointimal growth in patients with type 2 diabetes after zotarolimus-eluting stent implantation.
Hong SJ; Kim ST; Kim TJ; Kim EO; Ahn CM; Park JH; Kim JS; Lee KM; Lim DS
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2655-65. PubMed ID: 21030718
[TBL] [Abstract][Full Text] [Related]
31. Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials.
Rosmarakis ES; Falagas ME
Am Heart J; 2007 Jul; 154(1):144-50. PubMed ID: 17584567
[TBL] [Abstract][Full Text] [Related]
32. Coronary stent restenosis in patients treated with cilostazol.
Douglas JS; Holmes DR; Kereiakes DJ; Grines CL; Block E; Ghazzal ZM; Morris DC; Liberman H; Parker K; Jurkovitz C; Murrah N; Foster J; Hyde P; Mancini GB; Weintraub WS;
Circulation; 2005 Nov; 112(18):2826-32. PubMed ID: 16246948
[TBL] [Abstract][Full Text] [Related]
33. Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation.
Kitahara H; Kobayashi Y; Iwata Y; Fujimoto Y; Komuro I
Am J Cardiol; 2011 Jul; 108(2):214-9. PubMed ID: 21565324
[TBL] [Abstract][Full Text] [Related]
34. A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study).
Takagi T; Okura H; Kobayashi Y; Kataoka T; Taguchi H; Toda I; Tamita K; Yamamuro A; Sakanoue Y; Ito A; Yanagi S; Shimeno K; Waseda K; Yamasaki M; Fitzgerald PJ; Ikeno F; Honda Y; Yoshiyama M; Yoshikawa J;
JACC Cardiovasc Interv; 2009 Jun; 2(6):524-31. PubMed ID: 19539256
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of pioglitazone in patients with ST elevation myocardial infarction treated with primary stent implantation.
Kaneda H; Shiono T; Miyashita Y; Takahashi S; Taketani Y; Domae H; Matsumi J; Mizuno S; Minami Y; Sugitatsu K; Saito S
Heart; 2009 Jul; 95(13):1079-84. PubMed ID: 19321493
[TBL] [Abstract][Full Text] [Related]
36. The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance.
Yoshida O; Hirayama H; Nanasato M; Watanabe T; Murohara T
Am Heart J; 2005 Jan; 149(1):e2. PubMed ID: 15660025
[TBL] [Abstract][Full Text] [Related]
37. Radiation therapy to inhibit restenosis: early clinical results.
Teirstein PS; Massullo V; Jani S; Tripuraneni P
Mt Sinai J Med; 2001 May; 68(3):192-6. PubMed ID: 11373691
[TBL] [Abstract][Full Text] [Related]
38. Effects of L-arginine supplementation on endothelial function after stent implantation.
Dudek D; Heba G; Bartuś S; Partyka Ł; Dembińska-Kieć A; Huk J; Legutko J; Dubiel JS
Kardiol Pol; 2002 Nov; 57(11):389-97; discussion 398. PubMed ID: 12960999
[TBL] [Abstract][Full Text] [Related]
39. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.
Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N
Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model.
Morton AC; Arnold ND; Gunn J; Varcoe R; Francis SE; Dower SK; Crossman DC
Cardiovasc Res; 2005 Dec; 68(3):493-501. PubMed ID: 16099441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
